<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Soluble complement-fixing (CF) antigens of the virus-producing and virus-nonproducing P3HR-1 and RAJI Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines and Hk-Ly-28 nasopharyngeal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell line, identified by use of <z:mp ids='MP_0001799'>viral</z:mp> capsid antigen-positive human sera, could readily be distinguished by differences in their stability to chemical and physical conditions </plain></SENT>
<SENT sid="1" pm="."><plain>The P3HR-1 soluble CF antigen lost titer when heated or exposed to acid <z:chebi fb="0" ids="49706">perchlorate</z:chebi> under conditions in which RAJI and Hk-Ly-28 soluble antigens were stable </plain></SENT>
<SENT sid="2" pm="."><plain>Differences in solubility were also found </plain></SENT>
<SENT sid="3" pm="."><plain>These results contribute not only to the interpretation of the relationship of Epstein-Barr virus (EBV)-associated components of RAJI to P3HR-1 and Hk-Ly-28 cell lysates but also to the selection of conditions for the development of identification tests and purification procedures for CF antigens and antibodies of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, <z:e sem="disease" ids="C0153392" disease_type="Neoplastic Process" abbrv="">nasopharyngeal cancer</z:e>, and other EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
</text></document>